Replimune Group, Inc. (REPL)

NASDAQ: REPL · IEX Real-Time Price · USD
8.17
-0.08 (-0.97%)
At close: Mar 28, 2024, 4:00 PM
8.37
+0.20 (2.45%)
After-hours: Mar 28, 2024, 5:38 PM EDT

Replimune Group Market Cap

Replimune Group has a market cap or net worth of $506.45 million as of March 28, 2024. Its market cap has decreased by -55.30% in one year.

Market Cap
506.45M
Enterprise Value
114.27M
1-Year Change
-55.30%
Ranking
Category
Stock Price
$8.17

Market Cap Chart

Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $506.45M, an increase of 8.33%. That is a compound annual growth rate of 1.42%.

History

DateMarket Cap% Change
Mar 27, 2024506.40M7.27%
Mar 26, 2024472.10M-4.47%
Mar 25, 2024494.20M-1.83%
Mar 22, 2024503.40M-
Mar 21, 2024503.40M1.10%
Mar 20, 2024497.90M-1.81%
Mar 19, 2024507.10M-0.24%
Mar 18, 2024508.30M-2.92%
Mar 15, 2024523.60M-3.52%
Mar 14, 2024542.70M-1.56%
Mar 13, 2024551.30M3.22%
Mar 12, 2024534.10M-1.69%
Mar 11, 2024543.30M-1.98%
Mar 8, 2024554.30M2.14%
Mar 7, 2024542.70M-1.88%
Mar 6, 2024553.10M4.65%
Mar 5, 2024528.50M-3.05%
Mar 4, 2024545.10M-1.00%
Mar 1, 2024550.60M4.54%
Feb 29, 2024526.70M-1.50%
Feb 28, 2024534.70M-1.69%
Feb 27, 2024543.90M2.91%
Feb 26, 2024528.50M4.61%
Feb 23, 2024505.20M3.52%
Feb 22, 2024488.00M4.05%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Solid Biosciences 512.74M
Orthofix Medical 507.23M
SNDL Inc. 497.23M
Nevro 497.01M
CareDx 495.52M
IGM Biosciences 493.81M
Lyell Immunopharma 492.95M
Revance Therapeutics 489.82M
Market Cap Rankings